Myriad Genetics

$30.49
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.28 (+0.93%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell MYGN and other stocks, options, and ETFs commission-free!

About MYGN

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic test. It operates through the Diagnostics and Other segments. The Diagnostics segment provides testing and collaborative development of testing that is designed to asses an individual's risk of developing a disease later in life. The Other segment offers products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients; and also includes corporate services such as finance, human resources, legal, and information technology. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT. The listed name for MYGN is Myriad Genetics, Inc. Common Stock.

CEO
Paul J. Diaz
Employees
2,700
Headquarters
Salt Lake City, Utah
Founded
1991
Market Cap
2.20B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
717.38K
High Today
$31.05
Low Today
$29.41
Open Price
$30.48
Volume
942.47K
52 Week High
$31.60
52 Week Low
$9.24

MYGN News

BenzingaFeb 24

Recap: Myriad Genetics Q2 Earnings

Shares of Myriad Genetics (NASDAQ:MYGN) were unchanged in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share dec
BenzingaFeb 22

A Preview Of Myriad Genetics's Earnings

Myriad Genetics (NASDAQ:MYGN) will be releasing its next round of earnings this Tuesday, February 23. For all of the relevant information, here is your guide fo

MYGN Earnings

-$0.47
-$0.16
$0.16
$0.47
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
-$0.12 per share
Actual
-$0.12 per share
Replay Earnings Call

You May Also Like

PALL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure